Rede Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.07M Hold
37,085
3.26% 3
2025
Q4
$7.67M Buy
37,085
+32,743
+754% +$6.47M 2.67% 4
2025
Q3
$805K Sell
4,342
-32,972
-88% -$5.65M 0.63% 34
2025
Q2
$5.7M Sell
37,314
-485
-1% -$74.5K 2.06% 5
2025
Q1
$6.27M Sell
37,799
-459
-1% -$71.8K 2.21% 4
2024
Q4
$5.53M Buy
38,258
+173
+0.5% +$26.8K 2.12% 6
2024
Q3
$6.17M Hold
38,085
2.36% 4
2024
Q2
$5.57M Buy
38,085
+14
+0% +$2.08K 5.13% 4
2024
Q1
$6.02M Buy
38,071
+229
+0.6% +$36.5K 2.52% 4
2023
Q4
$5.93M Buy
37,842
+35
+0.1% +$5.37K 2.81% 3
2023
Q3
$5.89M Sell
37,807
-3,365
-8% -$555K 2.95% 3
2023
Q2
$6.81M Sell
41,172
-14
-0% -$2.26K 3.24% 3
2023
Q1
$6.38M Buy
41,186
+5
+0% +$807 3.33% 3
2022
Q4
$7.27M Sell
41,181
-167
-0.4% -$28.8K 3.89% 2
2022
Q3
$6.75M Sell
41,348
-8
-0% -$1.35K 4.01% 3
2022
Q2
$7.34M Buy
41,356
+9
+0% +$1.6K 4.26% 2
2022
Q1
$7.33M Buy
41,347
+78
+0.2% +$13.3K 3.44% 3
2021
Q4
$7.06M Buy
41,269
+10
+0% +$1.64K 3.55% 3
2021
Q3
$6.66M Buy
41,259
+738
+2% +$126K 3.55% 3
2021
Q2
$6.67M Buy
40,521
+1
+0% +$166 3.56% 3
2021
Q1
$6.66M Buy
40,520
+2
+0% +$324 3.86% 3
2020
Q4
$6.38M Buy
+40,518
New +$5.98M 4.34% 3

Other funds holding JNJ

Rede Wealth's JNJ Position: Q1 2026 in Review

Rede Wealth held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 37,085 shares worth $9.07M. The position accounts for 3.26% of the portfolio, ranked #3.

Rede Wealth first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Rede Wealth held 37,085 shares of Johnson & Johnson worth $9.07M as of Q1 2026.
  • Rede Wealth left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 3.26% of Rede Wealth's portfolio in Q1 2026, its #3 holding.
  • Rede Wealth first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Rede Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.